Showing results (171-180 of 829) with videos related to
Sort By:
Pageof 83
Plos One|October 15, 2008
Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized studySøren Søgaard Lund, Lise Tarnow, Anne Sofie Astrup, et al.Journal of Diabetes and Its Complications|May 3, 2017
Effect of weight reductions on estimated kidney function: Post-hoc analysis of two randomized trialsBernt Johan von Scholten, Melanie J Davies, Frederik Persson, et al.Journal of Diabetes and Its Complications|April 29, 2020
Effect of dapagliflozin on cardiac function in people with type 2 diabetes and albuminuria - A double blind randomized placebo-controlled crossover trialMie K Eickhoff, Flemming J Olsen, Marie Frimodt-Møller, et al.Clinical Kidney Journal|December 4, 2023
Design and methodology of the PRIMETIME 1 cohort study: PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathyKarina Haar Jensen, Frederik Persson, Ditte Hansen, et al.Cardiovascular Diabetology|April 8, 2018
Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuriaGemma E Currie, Bernt Johan von Scholten, Sheon Mary, et al.Plos One|March 3, 2021
Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuriaSigne Abitz Winther, Jens Christian Øllgaard, Tine Willum Hansen, et al.Diabetes Care|April 13, 2018
Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and MicroalbuminuriaDaniel G K Rasmussen, Tine W Hansen, Bernt J von Scholten, et al.European Journal of Endocrinology|December 31, 2005
Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patientsLars Melholt Rasmussen, Lise Tarnow, Troels Krarup Hansen, et al.Diabetes Care|August 27, 2005
Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over studyKasper Rossing, Katrine J Schjoedt, Ulla M Smidt, et al.Journal of the American Society of Nephrology : JASN|October 22, 2003
Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathyPeter Jacobsen, Lise Tarnow, Bendix Carstensen, et al.Pageof 83